<SEC-DOCUMENT>0001193125-23-095317.txt : 20230407
<SEC-HEADER>0001193125-23-095317.hdr.sgml : 20230407
<ACCEPTANCE-DATETIME>20230407164101
ACCESSION NUMBER:		0001193125-23-095317
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230407
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230407
DATE AS OF CHANGE:		20230407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00100
		FILM NUMBER:		23809075

	BUSINESS ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431
		BUSINESS PHONE:		561-961-1900

	MAIL ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d485631d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:txmd="http://www.therapeuticsmd.com/20230407" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-04-07_to_2023-04-07">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-04-07_to_2023-04-07">0000025743</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="txmd-20230407.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-04-07_to_2023-04-07"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000025743</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-07</xbrli:startDate> <xbrli:endDate>2023-04-07</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-04-07_to_2023-04-07">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt:datemonthdayyearen">April 7, 2023</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g485631g82u58.jpg" alt="LOGO" /></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-04-07_to_2023-04-07">THERAPEUTICSMD, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in its Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-04-07_to_2023-04-07">001-00100</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-04-07_to_2023-04-07">87-0233535</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-04-07_to_2023-04-07">951 Yamato Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-04-07_to_2023-04-07">Suite 220</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-04-07_to_2023-04-07">Boca Raton</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-04-07_to_2023-04-07">FL</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-04-07_to_2023-04-07">33431</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Office) (Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-04-07_to_2023-04-07">(561)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-04-07_to_2023-04-07">961-1900</ix:nonNumeric></span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of Each Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of Each Exchange<br />on Which Registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-04-07_to_2023-04-07">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-04-07_to_2023-04-07">TXMD</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230-405) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-04-07_to_2023-04-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information provided in Item 7.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated in this Item 2.02 by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;7, 2023,&#160;TherapeuticsMD, Inc., a Nevada corporation (the &#8220;Company&#8221;), issued a press release&#160;announcing its financial results for the full year ended December&#160;31, 2022. A&#160;copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and the information contained in Exhibit 99.1 is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in any such filing, regardless of any general incorporation language in the filing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company does not have, and expressly disclaims, any obligation to release publicly any updates or any changes in its expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160;&#160;&#160;Exhibits. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="text-decoration:underline">Exhibit Index</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:7%"></td>
<td style="width:90%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="3" style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap">Exhibit&#160;No.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d485631dex991.htm">Press Release from TherapeuticsMD, Inc., dated April&#160;7, 2023, entitled &#8220;TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition.&#8221; </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:46%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: April&#160;7, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">THERAPEUTICSMD, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marlan Walker</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Marlan Walker</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d485631dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 99.1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g485631g38r26.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model
Transition </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BOCA RATON, Fla. </B>&#150; <B>April</B><B></B><B>&nbsp;7, 2023</B> &#150; TherapeuticsMD, Inc. (&#147;TherapeuticsMD&#148; or the
&#147;Company&#148;) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December&nbsp;31, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;As a result of the transaction with Mayne Pharma Group Limited (ASX: MYX) (&#147;Mayne Pharma&#148;) that closed at
<FONT STYLE="white-space:nowrap">year-end,</FONT> in which TherapeuticsMD granted Mayne Pharma an exclusive license to commercialize TherapeuticsMD&#146;s products in the United States, we repaid our debt, redeemed our outstanding preferred stock,
eliminated our commercial and manufacturing infrastructure, and downsized our remaining operations,&#148; said Marlan D. Walker, Chief Executive Officer of TherapeuticsMD. &#147;We look forward to continuing to streamline our operations as we
complete the transition to a virtual business model that collects royalties from Mayne Pharma and our other licensees. We also intend to explore other strategic pathways to create value for TherapeuticsMD shareholders,&#148; said Mr.&nbsp;Walker.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Full Year 2022 Financial Results </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Income
(Loss) from Continuing Operations </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Net income from continuing operations was $1.1&nbsp;million for the year ended December&nbsp;31, 2022, or $0.12
per basic share, compared to a net loss of $79.3&nbsp;million, or $9.96 per basic share, for 2021. The increase in net income was a result of an increase in license revenue due to the Mayne Pharma transaction. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>License Revenues from Continuing Operations </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">License revenues from continuing operations, which are revenues from continuing operations related to license
agreements, were $70.0&nbsp;million for the year ended December&nbsp;31, 2022, compared to $2.6&nbsp;million for 2021. The increase in license revenues was a result of the allocation of the initial upfront payment and guaranteed minimum royalties
from Mayne Pharma. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Total Operating Expenses from Continuing Operations </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total operating expenses from continuing operations for 2022 were $67.4&nbsp;million compared to
$80.7&nbsp;million for 2021. Total operating expenses from continuing operations for 2022 included $9.5&nbsp;million of restructuring expenses. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discontinued Operations </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Discontinued operations, which include the Company&#146;s commercial operations related to the sale of ANNOVERA<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP><SUP STYLE="font-size:75%; vertical-align:top">,</SUP> IMVEXXY<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, BIJUVA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, and
prescription prenatal vitamin products sold under the BocaGreenMD<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and vitaMedMD<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> brands, which are now licensed to Mayne Pharma,
resulted in product revenues of $80.7&nbsp;million for the year ended December&nbsp;31, 2022, compared to $84.4&nbsp;million for the same period in 2021. Net income from discontinued operations was $110.9&nbsp;million for the year ended
December&nbsp;31, 2022, compared to a net loss of $93.1&nbsp;million for 2021. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of December&nbsp;31, 2022, the Company&#146;s cash on hand totaled $38.1&nbsp;million compared with
$64.9&nbsp;million as of December&nbsp;31, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As of December&nbsp;31, 2022, the Company had no indebtedness for borrowed money, compared to $188.3&nbsp;million
as of December&nbsp;31, 2021. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Updates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the previously announced transaction with Mayne Pharma, TherapeuticsMD has significantly reduced its operating expenses. The termination of
certain members of the Company&#146;s executive management team and all other employees was completed by December&nbsp;31, 2022. Severance obligations for all employees other than executive officers were paid in full during the first quarter of
2023, and severance obligations for terminated executive officers will be paid in accordance with their employment agreements and separation agreements as previously disclosed. As of December&nbsp;31, 2022, the Company employed one full-time
employee primarily engaged in an executive position. The Company engaged external consultants, including certain former members of its management team, to support TXMD&#146;s relationship with current partners and assist with certain financial,
legal, and regulatory matters, and the continued wind-down of historical business operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total consideration paid to TherapeuticsMD for the
transaction with Mayne Pharma that closed on December&nbsp;30, 2022, included an upfront cash payment of $140.0&nbsp;million for the license grant and sale of certain assets, plus an additional approximately $13.1 million for the acquisition of net
working capital and prepaid royalties, which is subject to customary adjustments. In addition, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
TherapeuticsMD is eligible to receive up to $30.0&nbsp;million in milestone payments as well as royalties on net sales of between 7.5% and 8.0%, for a period of 20 years, with minimum annual
royalties of $3.0&nbsp;million per year for 12 years, adjusted for inflation at an annual rate of 3%, subject to certain further adjustments. The approximately $1.0&nbsp;million in prepaid royalties paid at closing will reduce the first four
quarterly royalty payments that would have otherwise been payable to TherapeuticsMD. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company used a portion of the proceeds to repay all obligations
under the Company&#146;s Financing Agreement with Sixth Street Specialty Lending, Inc. In addition, the Company also redeemed all 29,000 outstanding shares of its Series A Preferred Stock at a purchase price of $1,333 per share and paid certain
affiliates of Rubric Capital Management LP (&#147;Rubric&#148;) approximately $3.0&nbsp;million as a make-whole payment pursuant to the subscription agreements previously entered into between the Company and Rubric. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release by
TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD&#146;s objectives, plans and strategies as well as statements, other than historical
facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as &#147;believes,&#148;
&#147;hopes,&#148; &#147;may,&#148; &#147;anticipates,&#148; &#147;should,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;will,&#148; &#147;expects,&#148; &#147;estimates,&#148; &#147;projects,&#148; &#147;positioned,&#148; &#147;strategy&#148;
and similar expressions and are based on assumptions and assessments made in light of management&#146;s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate.
Forward-looking statements in this press release are made as of the date of this press release, and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of the company&#146;s control. Important factors that could cause actual results, developments and business
decisions to differ materially from forward-looking statements are described in the sections titled &#147;Risk Factors&#148; in the company&#146;s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> as well as reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> and include the following: whether Mayne Pharma will be
successful at commercializing the products that it licensed and acquired from TherapeuticsMD; whether the company is successful in winding down its operations and the costs associated therewith, including the company&#146;s ability to obtain any
additional financing necessary therefor and the any adjustments to the net working capital purchased as part of the Mayne Pharma transaction; whether the company is successful in identifying strategic pathways to create additional shareholder value;
the company&#146;s ability to remain listed on Nasdaq; the impact of product liability lawsuits; the impact of leadership transitions; and the volatility of the trading price of the company&#146;s common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>CONTACT: </U></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="52%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Marlan D. Walker</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lisa M. Wilson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">In-Site</FONT> Communications, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">561-961-1900</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-452-2793</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>lwilson@insitecony.com</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>txmd-20230407.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 4/8/2023 12:31:11 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:txmd="http://www.therapeuticsmd.com/20230407"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.therapeuticsmd.com/20230407"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="txmd-20230407_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="txmd-20230407_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>txmd-20230407_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 4/8/2023 12:31:11 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>txmd-20230407_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 4/8/2023 12:31:11 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="txmd-20230407.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g485631g38r26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g485631g38r26.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M-/8EEFC@B:2:18XUZLYP!^-+<>Q%;7]G>Y^RW<$^.OE2!L?E3::W$FGL<O\
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M_/JO_?=9V1T<T^Q<J34\Q^"__((UK_K^/\A75B=UZ''A=GZG2_$C_DGFM?\
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M0K*C_$1M7_A,=\._^2?:+_UP_J:*W\1A0_A(YCQ5_P EM\*_]<#_ #>M:?\
M!D8U/X\3#\6:/I&D_%0WWB6S,VB:H@VRY8+%( !SCZ?DV>U73E*5*T-T9U(Q
MC5O-:,W;[P]\*M.T]KV<61A"Y CNV=F]@ V2:A3KMV1JZ>'BKL?J$.AI\&-4
MN/#]H]K8W,1E$<@8-NR >I/I]*2YO;)2W"2C[!N"T.D^'H"_#_1 !C_1@:SK
M?Q&;4?X:.#U9=-NOC;-#XK*_85MU^Q+.<1$X&,YXQG=^-;QNJ/N'-+E=>U3;
MH:OQ!E\$6'A:[C6UTQ[^2(I;);QH75B.&^7H!US4T54<O(NLZ48/:YSFK_\
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g485631g82u58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g485631g82u58.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M'1%J6>\N/%OP_EU*)XKTP2"57&&#8P<_E25E!H=Y<\3H?BB0?A]J(/\ L?\
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M5WK%OIMSIVHF#5M-.Z&>09#\<[L>N*4)1O9CG"=KHQ-;\)^,_%.DO::MJ=A
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C^--%,#]XTT)_" ZT+<)"_P 0I=12W0C?=I@.'6D4.IB1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139718160284720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000025743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  07,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THERAPEUTICSMD, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-00100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0233535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Yamato Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca Raton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">961-1900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TXMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d485631d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="txmd-20230407.xsd" xlink:type="simple"/>
    <context id="duration_2023-04-07_to_2023-04-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000025743</identifier>
        </entity>
        <period>
            <startDate>2023-04-07</startDate>
            <endDate>2023-04-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-04-07_to_2023-04-07">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-04-07_to_2023-04-07"
      id="Hidden_dei_EntityCentralIndexKey">0000025743</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-04-07_to_2023-04-07">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-04-07_to_2023-04-07">2023-04-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-04-07_to_2023-04-07">THERAPEUTICSMD, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-04-07_to_2023-04-07">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-04-07_to_2023-04-07">001-00100</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-04-07_to_2023-04-07">87-0233535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-04-07_to_2023-04-07">951 Yamato Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-04-07_to_2023-04-07">Suite 220</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-04-07_to_2023-04-07">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-04-07_to_2023-04-07">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-04-07_to_2023-04-07">33431</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-04-07_to_2023-04-07">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-04-07_to_2023-04-07">961-1900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-04-07_to_2023-04-07">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-04-07_to_2023-04-07">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-04-07_to_2023-04-07">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-04-07_to_2023-04-07">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-04-07_to_2023-04-07">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-04-07_to_2023-04-07">TXMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-04-07_to_2023-04-07">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-04-07_to_2023-04-07">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
M-5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K
M!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1U
MW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@
M;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ((6'5F60>9(9
M 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL
M6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4
M'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I
M>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY
M'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?K
MT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;
M@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"
M% ,4    "  @A8=6!T%-8H$   "Q    $               @ $     9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ""%AU9+:]S'[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ""%
MAU:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ((6'5C%.#\=B!   +Q$  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ""%
MAU:?H!OPL0(  .(,   -              "  :8,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ ((6'5I>*NQS     $P(   L              ( !@@\
M %]R96QS+RYR96QS4$L! A0#%     @ ((6'5APX9>H_ 0  / (   \
M         ( !:Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ""%AU8D
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( ""%AU9ED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d485631d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d485631d8k.htm">d485631d8k.htm</File>
    <File>d485631dex991.htm</File>
    <File>txmd-20230407.xsd</File>
    <File>txmd-20230407_lab.xml</File>
    <File>txmd-20230407_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g485631g82u58.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d485631d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d485631d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "txmd-20230407_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "txmd-20230407_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "txmd-20230407.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "txmd",
   "nsuri": "http://www.therapeuticsmd.com/20230407",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d485631d8k.htm",
      "contextRef": "duration_2023-04-07_to_2023-04-07",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d485631d8k.htm",
      "contextRef": "duration_2023-04-07_to_2023-04-07",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.therapeuticsmd.com//20230407/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-095317-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-095317-xbrl.zip
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M)&\*HZKKU045/:,UGE$'_P8\<-GE6?:7B[SY"-^-6$ )]I!E?X;\X5.F+KR
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M=?$;)%1R&L*_F/T7D@B90EW-!ME3J."("FP9SX-WI;@)DBS']H?.0TW)0UG
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MYY4\J!V_1TK!Y:(>&R5W]QTK.JI(1,9Y8HI%*'TU^^;R HWADG[E7G<@,KS
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MYK5<I[X%MQK[@-M%.QQYQVPWKKWMRM8-,]N>YO:F/_7-5;-UZ.=/4$L#!!0
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MZ_F#L:(09)4@+X7TC*]%&X:'?+9>RCNNU);^E2OY+IK]XA&UYW]02P,$%
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M(YU8\C=02P$"% ,4    "  @A8=6:0CC5$D0   F90  #@
M@ $     9#0X-38S,60X:RYH=&U02P$"% ,4    "  @A8=6HBNB/4@0  #S
M/0  $0              @ %U$   9#0X-38S,61E>#DY,2YH=&U02P$"% ,4
M    "  @A8=6#B4@]/$+  !Q#   $0              @ 'L(   9S0X-38S
M,6<X,G4U."YJ<&=02P$"% ,4    "  @A8=62>8R>D,#  !>"P  $0
M        @ $,+0  ='AM9"TR,#(S,#0P-RYX<V102P$"% ,4    "  @A8=6
M8*32&GH&  "Y1@  %0              @ %^,   ='AM9"TR,#(S,#0P-U]L
M86(N>&UL4$L! A0#%     @ ((6'5@DN[,O%!   2RP  !4
M ( !*S<  '1X;60M,C R,S T,#=?<')E+GAM;%!+!08     !@ & '\!   C
%/      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
